Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer.
about
Targeting cancer testis antigens for biomarkers and immunotherapy in colorectal cancer: Current status and challengesIntravital imaging of SRF and Notch signalling identifies a key role for EZH2 in invasive melanoma cellsStructure of the Kinesin13-Microtubule Ring ComplexEvidence of colorectal cancer-associated mutation in MCAK: a computational report.Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour targetKIF2A silencing inhibits the proliferation and migration of breast cancer cells and correlates with unfavorable prognosis in breast cancer.Mitotic centromere-associated kinesin (MCAK): a potential cancer drug target.Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer.Intracellular targets for a phosphotyrosine peptidomimetic include the mitotic kinesin, MCAKMotor-dependent microtubule disassembly driven by tubulin tyrosinationKIF-2C expression is correlated with poor prognosis of operable esophageal squamous cell carcinoma male patients.The role of kinesin family proteins in tumorigenesis and progression: potential biomarkers and molecular targets for cancer therapy.Centrosome clustering and chromosomal (in)stability: a matter of life and death.Oncogenic role of kinesin proteins and targeting kinesin therapy.Molecular insight into the regulation and function of MCAK.Functional analysis of phosphorylation of the mitotic centromere-associated kinesin by Aurora B kinase in human tumor cellsPolo-like kinase 1 regulates the stability of the mitotic centromere-associated kinesin in mitosis.Tumor suppressor protein p53-mediated repression of human mitotic centromere-associated kinesin gene expression is exerted via down-regulation of Sp1 level.Bioinformatics analysis of SRSF1-controlled gene networks in colorectal cancer.KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancer.KIF2A overexpression and its association with clinicopathologic characteristics and unfavorable prognosis in colorectal cancer.
P2860
Q26774074-77DB66F7-FBFD-4B23-BD7B-7565AD084FA4Q27310093-7D12D32C-E7BD-4906-BF3B-9A911F654C6BQ27652865-E79CC4E2-683D-4220-97CB-027E17811E0AQ30429097-690E626C-6B5C-40F9-BFC5-3A91FFF71A75Q33503255-62272D66-3E5E-41F1-BCEA-1DE3E6025888Q33825733-ADFD6BE5-A606-4613-ABBD-334FCBEDA66DQ35764416-1367F247-2184-41CA-9346-36096692D96DQ36653584-6396588A-F4F5-4533-BC1C-161C6DCBC6B6Q37127445-D8C5C818-BCE7-495F-BFF6-E598F115988DQ37267631-8B0331E9-5CDA-40E0-BCE9-0F61B0E85947Q37697028-EAF55F50-7C9A-4EB1-A97B-AC912FA6601CQ37775925-BEF99A18-9E87-441C-BDBA-0A6A989BF7FFQ37885569-88B94F1D-52F5-44F0-B8EA-6997D30F52A1Q38084376-14CC1024-1237-445E-B531-F23E34BFA0DBQ38825915-BCFD6F63-75BC-482D-9FC3-179A3254F625Q38856254-36A268EC-2AFE-483E-A75C-3DC96C0B593FQ38984499-937CA688-7A64-4436-AC1E-187A71690B08Q47121352-8E1C1443-B56E-4C0E-A0E0-A7D6C51EF7FAQ47135933-18F9E661-577F-41BD-92C0-7F605E899899Q52595286-27B7E246-4F80-40E3-A27B-D2076E3A6E7DQ53217902-658A880B-BDD4-41DF-80A4-2D9F904AA75E
P2860
Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Mitotic centromere-associated ...... tastasis in colorectal cancer.
@ast
Mitotic centromere-associated ...... tastasis in colorectal cancer.
@en
type
label
Mitotic centromere-associated ...... tastasis in colorectal cancer.
@ast
Mitotic centromere-associated ...... tastasis in colorectal cancer.
@en
prefLabel
Mitotic centromere-associated ...... tastasis in colorectal cancer.
@ast
Mitotic centromere-associated ...... tastasis in colorectal cancer.
@en
P2093
P2860
P356
P1476
Mitotic centromere-associated ...... tastasis in colorectal cancer.
@en
P2093
K Ishikawa
N Haraguchi
Y Kamohara
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604379
P407
P577
2008-05-27T00:00:00Z